Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Minerva Ginecol ; 53(3): 165-70, 2001 Jun.
Artigo em Italiano | MEDLINE | ID: mdl-11395688

RESUMO

BACKGROUND: The Vesico-Vaginal Fistula (VVF) very often occur in tropical countries, but their treatment is usually not correct. METHODS: A surgical treatment was carried put on 68 patients affected by VVF from March 1986 to December 19997 in the Nazareth Hospital (Nairobi). Their mean age was 22 years old; 27 patients (39.7%) underwent surgery for the first time, while for 41 patients (60.2%) the treatment was repeated. Fourteen patients (20.5%) had also Vesico-Rectum-Vaginal Fistula (VRV). The VVF was cured with a transvaginal treatment using a Martius strip for 32 cases. For 16 cases both vaginal and abdominal treatment was performed in the same time using an abdominal muscle strip, which was inserted in the space between the vagina and bladder. In VRV and VVF combined cases, the VVF was treated in the following way: first of all, during the same session, the VVF was cured by making a colostomy and then, after 2 months VRV was treated. RESULTS: The follow-up took about 7.2 months; 62 patients (91.1%) recovered, for 6 cases treated only with transvaginal operation, it has been necessary a second surgical procedure owing to relapsing, and for 2 of them an abdominal muscle strip was used. CONCLUSIONS: In conclusion, while the transvaginal repair is satisfactory treatment for little fistula never surgically treated before, on the other hand the transabdominal vaginal treatment is the best cure forge large or relapsing fistulas.


Assuntos
Transtornos Puerperais/cirurgia , Retalhos Cirúrgicos , Fístula Vesicovaginal/cirurgia , Músculos Abdominais/transplante , Adulto , Feminino , Seguimentos , Humanos , Quênia , Recidiva , Reoperação , Fatores de Tempo
3.
København; WHO; 2018. (Health Evidence Network synthesis report, 56).
Monografia em Inglês | PIE | ID: biblio-1024615

RESUMO

The WHO European Region has faced high rates of external and internal migration in recent years, with concerns that this is contributing to the burden of tuberculosis (TB), multidrug-resistant TB (MDR-TB) and TB/HIV coinfection in some countries. This report examines evidence of effective and efficient service packages for the prevention, diagnosis and treatment of TB to inform strategies to address the TB burden in refugee and migrant populations. Significant regional variations were identified in both migration levels and TB burden in refugees and migrants, as well as in approaches to TB control, with low quality of evidence in many cases. While it is unlikely that a single strategy/package will be effective for all situations, the evidence highlights some common approaches that could guide policy-making and service development. TB elimination targets for the Region will not be met unless inequalities in access to screening and treatment for migrants are addressed, alongside efforts to tackle TB globally.


Assuntos
Humanos , Masculino , Feminino , Tuberculose/diagnóstico , Tuberculose/prevenção & controle , Tuberculose Resistente a Múltiplos Medicamentos/complicações , Tuberculose Latente/prevenção & controle , Refugiados , Migrantes , Avaliação de Programas e Projetos de Saúde , Europa (Continente)
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA